Frailty is associated with reduced cardiac rehabilitation use in Medicare patients, despite these individuals deriving the greatest mortality benefit.

Nutritional guidance to support safe weight loss is frequently lacking for adults with obesity or type 2 diabetes receiving semaglutide or tirzepatide.

The US Department of Veterans Affairs and DoD published updated recommendations for the primary care management of chronic kidney disease.

Persistent depression following transient ischemic attack is associated with a 4-fold increase in 5-year all-cause mortality and higher disability.

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

Researchers assessed whether US veterans with long COVID face an increased risk for emergency department visits compared with veterans who did not develop long COVID.

HealthDay News — Email communications can increase clinician engagement with prescription drug monitoring programs (PDMPs), according to a study published online Dec. 19 in JAMA Health Forum.

For patients with primary solid tumors receiving cancer therapy, clonal hematopoiesis of indeterminate potential is associated with an increased risk for CVD.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

For adults with T2DM, statin initiation is associated with reductions in all-cause mortality and major CVD risk.

Among persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant ...

The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).